减少黑人/非洲裔美国人的痴呆风险因素的认知处方:可行性,可接受性和初步疗效
Pariya L Fazeli1, Cierra Hopkins1, David E Vance1
1School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
Ethnicity & health
|July 18, 2023
概括
黑人/非洲裔美国人面临更高的阿尔茨海默氏症风险. 认知处方 (CogRx) 计划的试点研究表明,它是可行的,可以接受的,并且有效地改善该人口的痴呆知识和健康行为.
科学领域:
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
- 行为科学 行为科学
背景情况:
- 与白人相比,黑人/非洲裔美国人 (B/AAs) 患阿尔茨海默氏症和相关痴呆症的风险是白人的两倍.
- 健康行为是这种差异的一个重要驱动因素.
- 需要有效的干预措施来解决B/AA社区的痴呆风险.
研究的目的:
- 检查个性化多领域健康行为干预的可行性,可接受性和初步疗效,称为认知处方 (CogRx).
- 评估干预对中老年和老年人痴呆症知识和有针对性的健康行为的影响 B/AAs.
主要方法:
- 一项试点随机临床试验,涉及39名45-65岁的社区住户B/AA参与者,没有认知障碍.
- 参与者被随机分为三个组:CogRx,精神教育或无接触对照组.
- CogRx组在五个领域获得了量身定制的信息和目标设定:身体活动,认知活动,社交活动,饮食和睡眠.
主要成果:
- 该CogRx计划显示了高保留率,并得到了参与者的好评.
- 在CogRx和精神教育组的参与者在痴呆知识方面表现出最大的改善.
- 与对照组相比,CogRx组在认知,身体和休活动方面表现出有利的增长,而CogRx和精神教育组的睡眠结果都改善了.
结论:
- 该CogRx计划是可行的,可以接受的,并显示在提高痴呆知识和健康行为的初步有效性.
- 像CogRx这样以人为中心的痴呆症预防方法需要进一步调查和在不同人群中进行更大规模的测试.
- 这些发现可以为减少痴呆风险的临床和公共卫生建议提供信息.
更多相关视频
相关概念视频
01:30Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
158
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
158
01:22Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
01:30Cognitive Development During Adulthood
159
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
159
01:26Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
01:25Cognitive Therapy
181
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
181